 |
PDBsum entry 1ayc
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase(sh2 domain)
|
PDB id
|
|
|
|
1ayc
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Crystal structures of peptide complexes of the amino-Terminal sh2 domain of the syp tyrosine phosphatase.
|
 |
|
Authors
|
 |
C.H.Lee,
D.Kominos,
S.Jacques,
B.Margolis,
J.Schlessinger,
S.E.Shoelson,
J.Kuriyan.
|
 |
|
Ref.
|
 |
Structure, 1994,
2,
423-438.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
BACKGROUND: Src homology 2 (SH2) domains bind to phosphotyrosine residues in a
sequence-specific manner, and thereby couple tyrosine phosphorylation to changes
in the localization or catalytic activity of signal transducing molecules.
Current understanding of SH2 specificity is based on the structures of
SH2-peptide complexes of the closely-related Src and Lck tyrosine kinases. The
tyrosine phosphatase Syp contains two SH2 domains that are relatively divergent
from those of the tyrosine kinases, with distinct target specificities, and is
thus well suited for structural studies aimed at extending our understanding of
SH2 specificity. RESULTS: Crystal structures of the amino-terminal SH2 domain of
Syp in separate complexes with two high-affinity peptides, in complex with a
non-specific peptide and in the uncomplexed form have been determined at between
2 A and 3 A resolution. The structure of the SH2 domain and the mode of
high-affinity peptide binding is essentially similar to that seen in the Src and
Lck structures. However, the binding interface is more extensive in Syp.
CONCLUSIONS: Most SH2 targets have hydrophobic residues at the third position
following the phosphotyrosine, and the Syp structure confirms that the peptide
is anchored to the SH2 surface by this residue and by the phosphotyrosine. In
addition, the Syp structure has revealed that sequence specificity can extend
across the five residues following the phosphotyrosine, and has shown how the
SH2 domain's surface topography can be altered with resulting changes in
specificity, while conserving the structure of the central core of the domain.
|
 |
 |
 |
|
 |
Figure 4.
Figure 4. Comparison of the Syp and Src SH2 domains. The
polypeptide backbones of the Syp and Src SH2 domains are shown
as red and white tubes, respectively. The YEEI peptide (Src) is
shown in yellow and the IRS1-895 and PDGFR-1009 peptides (Syp)
are shown in orange and blue, respectively. The view is
approximately perpendicular to the peptide-binding surface. The
two structures were first superimposed with the program O [44]
and displayed using Insight (Biosym Technologies). Figure 4.
Comparison of the Syp and Src SH2 domains. The polypeptide
backbones of the Syp and Src SH2 domains are shown as red and
white tubes, respectively. The YEEI peptide (Src) is shown in
yellow and the IRS1-895 and PDGFR-1009 peptides (Syp) are shown
in orange and blue, respectively. The view is approximately
perpendicular to the peptide-binding surface. The two structures
were first superimposed with the program O [[3]44] and displayed
using Insight (Biosym Technologies).
|
 |
|
 |
 |
|
The above figure is
reprinted
by permission from Cell Press:
Structure
(1994,
2,
423-438)
copyright 1994.
|
 |
|
Secondary reference #1
|
 |
|
Title
|
 |
Binding of a high affinity phosphotyrosyl peptide to the src sh2 domain: crystal structures of the complexed and peptide-Free forms.
|
 |
|
Authors
|
 |
G.Waksman,
S.E.Shoelson,
N.Pant,
D.Cowburn,
J.Kuriyan.
|
 |
|
Ref.
|
 |
Cell, 1993,
72,
779-790.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
|
 |
|
Secondary reference #2
|
 |
|
Title
|
 |
Structures of sh2 and sh3 domains
|
 |
|
Authors
|
 |
J.Kuriyan,
D.Cowburn.
|
 |
|
Ref.
|
 |
curr opin struct biol, 1993,
3,
828.
|
 |
 |
|
Secondary reference #3
|
 |
|
Title
|
 |
Crystal structure of the phosphotyrosine recognition domain sh2 of V-Src complexed with tyrosine-Phosphorylated peptides.
|
 |
|
Authors
|
 |
G.Waksman,
D.Kominos,
S.C.Robertson,
N.Pant,
D.Baltimore,
R.B.Birge,
D.Cowburn,
H.Hanafusa,
B.J.Mayer,
M.Overduin,
M.D.Resh,
C.B.Rios,
L.Silverman,
J.Kuriyan.
|
 |
|
Ref.
|
 |
Nature, 1992,
358,
646-653.
|
 |
|
PubMed id
|
 |
|
 |
 |
|
|
 |
|
|
|
|
 |